Industry News

NeuroDerm stated on Thursday that it recorded a net loss of USD7.0m for the second quarter ended 30 June 2016.. This marks a decline in earnings when compared with a lower net loss of USD5.8m for the corresponding period in 2015.. The company said the increase in net loss in the second quarter 2016 was primarily due to the increase in research and development expenses, net, which were partially offset by a decrease in financial expenses as a result of a change..."/>
NeuroDerm incurs higher net loss of USD7.0m in Q2 2016
NeuroDerm said on Thursday that it has started enrollment of patients with Parkinson's disease under its Phase III efficacy trial of its low-dose continuous, subcutaneously delivered levodopa/carbidopa liquid formulation ND0612L. The company added that iNDiGO is a 16- week, international, multicentre, randomised, double-blind, placebo controlled, parallel group study designed to compare the efficacy, safety and tolerability of continuous..."/>
NeuroDerm initiaties iNDiGO trial of ND0612L in Parkinson’s Disease patients
Viking Therapeutics revealed on Thursday the execution of a USD12.5m common stock purchase agreement with Aspire Capital Fund. Pursuant to the agreement, Aspire Capital has initially acquired USD500, 000 of common stock from Viking at USD1.50 per share. Based on the market price at the time of each sale, Aspire Capital has committed to purchase up to an additional USD12.0m in shares of common stock over the next 30 months after the Securities and..."/>
Viking Therapeutics signs USD12.5m common stock purchase agreement with Aspire Capital
Celyad widens loss in H1 2016
ACETO Corporation on Thursday declared a regular quarterly dividend of USD0.065 per share of the company's common stock. ACETO stated that this new regular quarterly dividend per common share is up 8.3% from the prior payment. This higher quarterly cash dividend is payable on 20 September 2016 to shareholders of record as of 9 September 2016.."/>
ACETO's board approves 8.3% rise in cash dividend
Baxter's industry-leading AMIA APD system with SHARESOURCE, REVACLEAR high-flux dialyzer and CRRT products. DEERFIELD, Ill.- Baxter International Inc., a global leader in renal care, and Satellite Healthcare, a leading, national not-for-profit and the sixth largest provider of patient-centered dialysis and kidney disease..."/>
Baxter and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients
MannKind Corporation, a developer of devices for treatment of diabetes. Before his death, Mann staged offerings for the company on both Nasdaq and the Tel Aviv Stock Exchange."/>
Alfred Mann's legacy stimulates Israeli innovation [Globes, Tel Aviv, Israel]
GlaxoSmithKline Pharmaceuticals Ltd shares have lost a fifth of their value. The company's financial performance has been hit by supply constraints in FY16 and some of that has continued into FY17 as well. Price controls have hurt too."/>
GSK Pharma: in the recovery room [Mint, New Delhi]
Mylan NV and Biocon Ltd on Thursday said the European Medicines Agency has agreed to review Mylan's application seeking permission to bring Trastuzumab to Europe. Trastuzumab is a proposed biosimilar--copycat version of a biotech drug--that they developed together to treat certain types of breast and gastric cancers. A biosimilar is a complex biological product that follows a different approval pathway compared to chemical drugs."/>
European regulator EMA to review Biocon-Mylan cancer drug [Mint, New Delhi]
Insys Therapeutics deceptively marketed and sold Subsys-- a spray form of the prescription opioid drug fentanyl-- to physicians treating patients for conditions such as neck and back pain. "This drug company's desire for increased..."/>
Illinois sues drugmaker, alleges it pushed opioid spray for non-FDA use [Chicago Tribune]
Medtronic PLC in its fiscal first quarter despite a dip in sales. The company reported unadjusted net income of $929 million, or 66 cents per share, compared with $820 million, or 57 cents a share for the same period a year ago. Its adjusted net income of $1.03 per share beat Wall Street estimates by 2 cents."/>
Medtronic beats estimates despite a decline in sales [Star Tribune (Minneapolis)]
WALGREENS BOOTS ALLIANCE BUYS ANOTHER USD 1.19 BN OF AMERISOURCEBERGEN SHARES VIA WARRANTS EXERCISE US-based drug retailing chain Walgreens Boots Alliance, Inc. has exercised these warrants and purchased 22,696,912 shares of US-based pharmaceutical sourcing and distribution services company AmerisourceBergen common stock for an aggregate payment of approximately USD 1.19 bn using cash..."/>
M and A Navigator: Deal pipeline –26 August
Medtronic Spine, a division of Dublin-based medical device maker Medtronic Plc, today reported a 5.8 percent decline in global revenue for the first quarter. For the quarter that ended July 29, the division reported revenue of $645 million, compared with $685 million a year ago. The company reported that new products and procedural innovation are factors that should lead to improved results."/>
Memphis-based Medtronic Spine revenue down 6 percent [The Commercial Appeal, Memphis, Tenn.]
Transition Therapeutics Inc. is pleased to announce that the Company has received shareholder approval for the previously announced plan of arrangement involving Transition, OPKO Health, Inc., OPKO Global Holdings, Inc. and the Transition Shareholders. A total of 24,586,901 common shares, approximately 63.4% of the outstanding common shares, were represented at the meeting of Transition Shareholders in person or by proxy. The Arrangement was..."/>
Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
Transition Therapeutics Inc. is pleased to announce that the Company has received shareholder approval for the previously announced plan of arrangement involving Transition, OPKO Health, Inc., OPKO Global Holdings, Inc. and the Transition Shareholders. A total of 24,586,901 common shares, approximately 63.4% of the outstanding common shares, were represented at the meeting of Transition Shareholders in person or by proxy."/>
Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
Mettler-Toledo International Inc. will replace Johnson Controls Inc. in the S&P 500, S&P SmallCap 600 constituent Monolithic Power Systems, Inc. will replace Mettler-Toledo in the S&P MidCap 400, and WCI Communities Inc. will replace Monolithic Power Systems in the S&P SmallCap 600 after the close of..."/>
Mettler-Toledo International Set to Join the S&P 500; Monolithic Power Systems to Join S&P MidCap 400; WCI Communities and Nautilus to Join S&P SmallCap 600
INC Research Holdings, Inc., a leading global Phase I to Phase IV contract research organization, today announced that it will participate in two upcoming investor conferences. Presenting at the conferences will be Greg Rush, Chief Financial Officer.. Rush is scheduled to present during the upcoming 2016 Wells Fargo Healthcare Conference on Wednesday, Sept. 7, 2016 at 1:45 p.m. Eastern Time."/>
INC Research to Present at Upcoming September Conferences
LeMaitre Vascular, Inc. announced today that JJ Pellegrino, Chief Financial Officer, will present at the 9 th Annual Barrington Research Fall Investment Conference on Thursday, September 8, 2016 at the Four Seasons Hotel in Chicago, IL.. For more information or to register, please visit the conference website at www.brai.com. LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that..."/>
LeMaitre Vascular to Attend the 9th Annual Barrington Research Fall Investment Conference on September 8, 2016

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary646 Articles
Information Technology585 Articles
Financials498 Articles
Health Care348 Articles
Industrials342 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.